Supernus
SUPN
Supernus (SUPN) news
Recent news
Indivior Pharmaceuticals - Special dividend payment contingent on closing of Supernus merger expected Nov 2, 2026
Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) and Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) have announced a definitive agreement to merge in a tax-free all-stock transaction, creating a combined entity named Supernus, Inc. The merger is expected to close in the fourth quarter of 2026, pending…
AInvest Wire · Sep 17, 2026Indivior dividend contingent on merger with Supernus
AInvest Wire · Sep 17, 2026Supernus: deal includes termination fee of up to $174M
AInvest Wire · Aug 3, 2026Indivior Pharmaceuticals Inc: Supernus must pay co termination fee of $101 mln if the merger agreement is terminated under certain circumstances
AInvest Wire · Aug 3, 2026Supernus shares extend gains to rise 17%, Indivior up 1.7%
AInvest Wire · Aug 3, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.